Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wolf

Showing results (601-610 of 647) with videos related to

Pageof 65
Sort By:
Leukemia|January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disordersP Valent, K Sotlar, K Blatt, et al.
Nature Communications|July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster modelCarolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Nature Communications|August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal modelsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Msystems|October 9, 2025
High-throughput cytological profiling uncovers genotype-phenotype associations in <i>Mycobacterium tuberculosis</i> clinical isolatesQingyun Liu, Yue J Liu, Ruiyuan Liu, et al.
Biorxiv : the Preprint Server for Biology|December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferretsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Science (New York, N.Y.)|December 2, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
Human Reproduction (Oxford, England)|August 7, 2021
Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccinationY Bentov, O Beharier, A Moav-Zafrir, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
Hepatology Communications|July 24, 2023
Hepatocytes reprogram liver macrophages involving control of TGF-β activation, influencing liver regeneration and injuryStephanie D Wolf, Christian Ehlting, Sophia Müller-Dott, et al.
Pageof 65

Showing results (601-610 of 647) with videos related to

Sort By:
Pageof 65
Leukemia|January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disordersP Valent, K Sotlar, K Blatt, et al.
Nature Communications|July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster modelCarolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Nature Communications|August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal modelsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Msystems|October 9, 2025
High-throughput cytological profiling uncovers genotype-phenotype associations in <i>Mycobacterium tuberculosis</i> clinical isolatesQingyun Liu, Yue J Liu, Ruiyuan Liu, et al.
Biorxiv : the Preprint Server for Biology|December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferretsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Science (New York, N.Y.)|December 2, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
Human Reproduction (Oxford, England)|August 7, 2021
Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccinationY Bentov, O Beharier, A Moav-Zafrir, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
Hepatology Communications|July 24, 2023
Hepatocytes reprogram liver macrophages involving control of TGF-β activation, influencing liver regeneration and injuryStephanie D Wolf, Christian Ehlting, Sophia Müller-Dott, et al.
Pageof 65